NEO: the market wakes up and hints at a bullish reversal

NeoGenomics is breaking out of a mid-term descending wedge while forming a clear trend reversal structure with higher lows and steady support above key Fibonacci retracement levels. The 10.00–10.80 area acts as a consolidation range before a potential continuation of the upward move.

The price has already broken the descending trendline, retested it, and is now holding above the 0.705 Fibonacci zone. EMA 20/50/100 are shifting toward a bullish alignment, confirming renewed buying pressure. Volume is increasing — a classic behavior after a prolonged decline. If the structure holds, the next bullish impulse may form right after breaking the 10.80 resistance.

Fundamentally, NeoGenomics is recovering after a sector-wide selloff in biotech. The company continues to strengthen revenue growth, improve its diagnostics portfolio, and reduce financial pressure — factors that often precede medium-term trend reversals in this sector.

Tactical plan: consider long positions after a confirmed breakout above 10.80. Targets: 15.00 (primary supply zone) and 19.20 as an extended target at the upper boundary of the previous long-term structure. Invalidation: breakdown below 9.00.

If the bullish impulse confirms, the move to 15 and beyond may unfold much faster than the market currently expects.